Kristina Lorenz

Kristina Lorenz received her PhD at the Institute of Pharmacology and Toxicology in Würzburg in 2005 and worked as post-doctoral research fellow and group leader in Dresden and Würzburg, where she was appointed as Professor of Molecular Pharmacology in 2013 (University of Würzburg/Comprehensive Heart Failure Center).  In 2016 she became the Director of the Biomedical Research department at the Leibniz Institute for Analytical Sciences – ISAS – e.V. in Dortmund and Professor of “Mechanisms of cardiovascular diseases” at the University of Duisburg-Essen. Since 2019, she is the Head of the Institute of Pharmacology and Toxicology. Her research interest are signaling pathways involved in heart failure and cardiac hypertrophy with major focus on mitogen-activated protein kinase (MAPK) and G protein coupled receptor (GPCR) signaling